BioPharma Dive ٢٤ نوفمبر ٢٠٢٥ Biogen strikes deal with Versant-backed biotech to expand immune portfolio #Dayra Therapeutics #Versant-backed biotech
BioPharma Dive ٢١ نوفمبر ٢٠٢٥ A brain biotech’s top drug fails against MS #Contineum Therapeutics #Therapeutics dipped